Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer
Aaron DuVall, G., Tarabar, Dino, Seidel, Richard H., Elstad, Nancy L., Fowers, Kirk D.Volume:
20
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0b013e3283222c12
Date:
February, 2009
File:
PDF, 144 KB
english, 2009